🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 6 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/11/2025 39,80 43,59 39,30 40,47 +0,80% 10,77% 2.960.700
17/11/2025 41,28 41,58 39,75 40,15 -2,69% 4,43% 1.612.900
14/11/2025 39,85 41,79 39,33 41,26 +0,29% 6,16% 1.621.100
13/11/2025 40,72 41,50 40,21 41,14 -0,68% 3,17% 1.536.600
12/11/2025 41,96 43,20 41,14 41,42 -0,19% 4,90% 1.987.900
11/11/2025 39,45 41,52 38,93 41,50 +4,14% 6,57% 1.171.000
10/11/2025 40,85 42,00 39,77 39,85 +1,58% 5,46% 1.877.800
07/11/2025 39,23 39,34 37,35 39,23 -0,93% 5,07% 1.307.600
06/11/2025 40,27 40,94 39,50 39,60 -1,76% 3,58% 1.620.500
05/11/2025 37,63 40,55 37,56 40,31 +6,50% 7,95% 1.426.700
04/11/2025 38,60 39,31 37,77 37,85 -4,44% 3,99% 1.987.200
03/11/2025 41,99 43,20 39,28 39,61 -6,56% 9,34% 1.942.300
31/10/2025 42,32 43,69 41,31 42,39 +0,19% 5,62% 1.715.700
30/10/2025 39,92 43,33 39,70 42,31 +5,01% 9,10% 2.300.500
29/10/2025 39,26 40,75 38,65 40,29 +1,87% 5,35% 1.559.500
28/10/2025 39,23 40,48 38,84 39,55 +0,18% 4,18% 1.243.800
27/10/2025 39,10 40,10 38,63 39,48 +3,89% 3,76% 1.730.500
24/10/2025 37,96 38,34 36,88 38,00 +1,74% 3,85% 1.471.000
23/10/2025 37,63 38,23 36,73 37,35 -0,74% 3,99% 1.257.600
22/10/2025 38,75 39,09 36,90 37,63 -1,05% 5,65% 1.586.800
21/10/2025 38,45 39,56 38,02 38,03 -1,14% 4,01% 1.969.400
20/10/2025 37,67 38,56 36,91 38,47 +4,51% 4,39% 1.632.100
17/10/2025 38,20 39,36 36,57 36,81 -5,54% 7,30% 1.877.800
16/10/2025 38,25 40,29 38,19 38,97 +2,04% 5,49% 2.595.100
15/10/2025 36,42 38,63 36,02 38,19 +6,20% 7,17% 1.575.800
14/10/2025 35,27 36,41 34,61 35,96 -0,80% 5,09% 1.222.700
13/10/2025 35,67 37,07 35,50 36,25 +2,37% 4,40% 1.557.900
10/10/2025 36,00 36,10 34,91 35,41 -1,80% 3,31% 1.829.600
09/10/2025 36,91 37,15 35,94 36,06 -2,38% 3,28% 1.500.400
08/10/2025 36,90 37,30 36,00 36,94 +1,09% 3,52% 1.769.400